SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mongiat-Artus P, Teillac P. Role of luteinising hormone releasing hormone (LHRH) agonist in the management of prostate cancer. Eur Urol Suppl 2005; 4: 413
  • 2
    Tombal B. Appropiate castration with luteinising hormone releasing hormone (LHRH) agonist. What is the optimal level of testosterone. Eur Urol Suppl 2005; 4: 149
  • 3
    Sharifi R, Bruskewitz R, Gittleman M, Graham S, Hudson P, Stein B. Leuprorelin acetate 22.5 mg 12-week depot formulation in the treatment of patients with advanced prostate cancer. Clin Ther 1996; 18: 64757
  • 4
    Wheeler M, D’Souza A, Matadeen J, Croos P, Ciba Corning ACS. 180 testosterone assay evaluated. Clin Chem 1996; 42: 14459
  • 5
    Oefelein M, Feng A, Scolieri M, Ricchiuti D, Resnick M. Reassessment of the definition of castrate levels of testosterone: implications for clinical decision making. Urology 2000; 56: 10214
  • 6
    Morote J, Esquena S, Abascal J et al. Failure to maintain a suppressed level of serum testosterone during long-acting depot luteinizing hormone-releasing hormone agonist therapy in patients with advanced prostate cancer. Urol Int 2006; 77: 1358
  • 7
    Morote J, Esquena S, Abascal J et al. Behavior of free testosterone in patients with ptostate cancer on androgen deprivation therapy. Int J Biol Markers 2005; 20: 11922
  • 8
    Morote J, Orsola A, Planas J et al. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy. J Urol 2007; 178: 12905
  • 9
    Maes M, Mommen K, Hendrickx D et al. Components of biological variation, including seasonality, in blood concentrations of TSH, TT3, FTH, PRL, cortisol and testosterone in healthy volunteers. Clin Endocrinol 1997; 46: 5878
  • 10
    Levi F, Canon C, Touitou Y et al. Circadian rhythms in circulating T lymphocyte subtypes and plasma testosterone, total and free cortisol in five healthy men. Clin Exp Immunol 1988; 71: 32935
  • 11
    Reinberg A, Lagoguey M, Cesselin F et al. Circadian and circannual rhythms in plasma hormones and other variables of five healthy young human males. Acta Endocrinol (Copenh) 1978; 88: 41727
  • 12
    Reinberg A, Lagoguey M, Chauffournier J, Cesselin F. Circannual and circadian rhythms in plasma testosterone in five healthy young Parisian males. Acta Endocrinol (Copenh) 1975; 80: 7324
  • 13
    Crawford D, O’Donnell Morgentaler A, Stone N, Mills J. Diurnal serum testosterone variation in aging men: cross-sectional analysis from a large national screening program reveals only a modest decline beginning in the mid-afternoon. J Urol 2006; 4 (Suppl.): 426